You have free access to this content

British Journal of Clinical Pharmacology

Cover image for Vol. 60 Issue 5

November 2005

Volume 60, Issue 5

Pages 457–579

  1. Editors’ view

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacokinetics-Pharmacodynamics
    6. Interactions
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Letter to the editor
    1. You have free access to this content
      Prescribing statins (pages 457–458)

      J. K. Aronson and Chairman of the Editorial Board, British Journal of Clinical Pharmacology

      Article first published online: 19 OCT 2005 | DOI: 10.1111/j.1365-2125.2005.02521.x

  2. Pharmacodynamics

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacokinetics-Pharmacodynamics
    6. Interactions
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Letter to the editor
    1. You have free access to this content
      The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease (pages 459–468)

      Dean Patterson, Robert Kloner, Mark Effron, Jeffrey Emmick, Alun Bedding, Margaret Warner, Malcolm Mitchell, Simon Braat and Thomas MacDonald

      Article first published online: 1 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02479.x

  3. Pharmacokinetics

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacokinetics-Pharmacodynamics
    6. Interactions
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Letter to the editor
    1. You have free access to this content
      Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment (pages 469–476)

      Gregory Holmes, Lawrence Galitz, Peter Hu and William Lyness

      Article first published online: 1 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02476.x

    2. You have free access to this content
      Population plasma pharmacokinetics of 11C-flumazenil at tracer concentrations (pages 477–485)

      Catharina M. Van Rij, Alwin D. R. Huitema, Eleonora L. Swart, Henricus N. J. M. Greuter, Adriaan A. Lammertsma, Arie C. Van Loenen and Eric J. F. Franssen

      Article first published online: 15 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02487.x

  4. Pharmacokinetics-Pharmacodynamics

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacokinetics-Pharmacodynamics
    6. Interactions
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Letter to the editor
    1. You have free access to this content
      Fluvoxamine impairs single-dose caffeine clearance without altering caffeine pharmacodynamics (pages 486–493)

      Kerry E. Culm-Merdek, Lisa L. Von Moltke, Jerold S. Harmatz and David J. Greenblatt

      Article first published online: 27 JUL 2005 | DOI: 10.1111/j.1365-2125.2005.02467.x

  5. Interactions

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacokinetics-Pharmacodynamics
    6. Interactions
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Letter to the editor
    1. You have free access to this content
      Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin (pages 494–497)

      Hitoshi Ando, Shuichi Tsuruoka, Hayato Yanagihara, Koh-ichi Sugimoto, Masaaki Miyata, Yasushi Yamazoe, Toshinari Takamura, Shuichi Kaneko and Akio Fujimura

      Article first published online: 27 JUL 2005 | DOI: 10.1111/j.1365-2125.2005.02462.x

    2. You have free access to this content
      Effect of azole antifungals ketoconazole and fluconazole on the pharmacokinetics of dexloxiglumide (pages 498–507)

      Abhijeet S. Jakate, Partha Roy, Alpita Patel, Wattanaporn Abramowitz, Stefano Persiani, Julie Wangsa and Ram Kapil

      Article first published online: 19 JUL 2005 | DOI: 10.1111/j.1365-2125.2005.02465.x

    3. You have free access to this content
  6. Pharmacoepidemiology

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacokinetics-Pharmacodynamics
    6. Interactions
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Letter to the editor
    1. You have free access to this content
      Suicide and self-harm following prescription of SSRIs and other antidepressants: confounding by indication (pages 519–525)

      Rebecca C. Didham, Doug W. McConnell, Hayden J. Blair and David M. Reith

      Article first published online: 1 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02480.x

  7. Therapeutics

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacokinetics-Pharmacodynamics
    6. Interactions
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Letter to the editor
    1. You have free access to this content
      General practitioners’ adoption of new drugs and previous prescribing of drugs belonging to the same therapeutic class: a pharmacoepidemiological study (pages 526–533)

      Torben Dybdahl, Morten Andersen, Jakob Kragstrup, Ivar Sønbø Kristiansen and Jens Søndergaard

      Article first published online: 19 JUL 2005 | DOI: 10.1111/j.1365-2125.2005.02463.x

    2. You have free access to this content
      Socioeconomic gradient in use of statins among Danish patients: population-based cross-sectional study (pages 534–542)

      Reimar W. Thomsen, Søren P. Johnsen, Anne V. Olesen, Jens T. Mortensen, Henrik Bøggild, Jørn Olsen and Henrik T. Sørensen

      Article first published online: 13 SEP 2005 | DOI: 10.1111/j.1365-2125.2005.02494.x

    3. You have free access to this content
      Trends in prescribing and utilization of statins and other lipid lowering drugs across Europe 1997–2003 (pages 543–551)

      T. Walley, P. Folino-Gallo, P. Stephens, E. Van Ganse and EuroMedStat group

      Article first published online: 1 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02478.x

  8. Adverse drug effects

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacokinetics-Pharmacodynamics
    6. Interactions
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Letter to the editor
    1. You have free access to this content
      Calcium antagonists and deep gingival pockets in the population-based SHIP study (pages 552–559)

      Peter Meisel, Christian Schwahn, Ulrich John, Heyo K. Kroemer and Thomas Kocher

      Article first published online: 11 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02485.x

  9. Short reports

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacokinetics-Pharmacodynamics
    6. Interactions
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Letter to the editor
    1. You have free access to this content
    2. You have free access to this content
      Trimethoprim–sulphamethoxazole does not affect the pharmacokinetics of sirolimus in renal transplant recipients (pages 566–569)

      Ylva Böttiger, Christina Brattström, Lars Bäckman, Kerstin Claesson and James T. Burke

      Article first published online: 1 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02475.x

    3. You have free access to this content
      Mirtazapine-induced arthralgia (pages 570–572)

      Anneke Passier and Eugène Van Puijenbroek

      Article first published online: 1 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02481.x

    4. You have free access to this content
      Favourable dermal penetration of diclofenac after administration to the skin using a novel spray gel formulation (pages 573–577)

      Martin Brunner, Pejman Dehghanyar, Bernd Seigfried, Wolfgang Martin, Georg Menke and Markus Müller

      Article first published online: 11 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02484.x

  10. Letter to the editor

    1. Top of page
    2. Editors’ view
    3. Pharmacodynamics
    4. Pharmacokinetics
    5. Pharmacokinetics-Pharmacodynamics
    6. Interactions
    7. Pharmacoepidemiology
    8. Therapeutics
    9. Adverse drug effects
    10. Short reports
    11. Letter to the editor
    1. You have free access to this content
      Topiramate in non-approved indications and acute myopia or angle closure glaucoma (pages 578–579)

      Gloria Cereza, Consuelo Pedrós, Núria Garcia and Joan-Ramon Laporte

      Article first published online: 1 AUG 2005 | DOI: 10.1111/j.1365-2125.2005.02470.x

SEARCH

SEARCH BY CITATION